AMR cure: AdjuTec Pharma’s APC-148 enters pre-clinical trials

AdjuTec Pharma AS has partnered with Venus Remedies Limited to combat antimicrobial resistance (AMR). Venus Remedies will conduct preclinical evaluations of AdjuTec's APC-148 technology, which restores antibiotic effectiveness against drug-resistant bacteria. This collaboration aims to advance AMR research and address the growing global health threat posed by antibiotic resistance.